By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged...
Patient Advocacy and Support
NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global...
NEW YORK, NY — In a move that has sent shockwaves through the global philanthropic and medical...
OTTAWA – While the ringing of the "end-of-treatment" bell is often celebrated as a final victory over...
Introduction In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists, commonly known as GLP-1 medications, have revolutionized the...
NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
NEW YORK, NY – In a move that signals a new era for oncological philanthropy and scientific...
By [Your Name/Agency] October 10, 2026 OTTAWA – For many breast cancer patients, the sound of the...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged...
NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global...
